Araoz & Rueda acts for Dermapharm on €200m Euromed deal

Araoz & Rueda advised Dermapharm on the acquisition of the Spanish herbal extract manufacturer Euromed.

Dermapharm acquired Barcelona-based Euromed from US private equity fund The Riverside Company, which instructed Allen & Overy on the deal.

The transaction was valued at €200 million, according to Mergermarket.

Euromed is a manufacturer of herbal extracts for the pharmaceutical and cosmetic industries. In 2019, Euromed is expected to generate revenues of €70 million and earnings before interest, taxes, depreciation and amortization (EBITDA) of €20 million.

The Araoz & Rueda team was led by partner Alejandro Fernández de Araoz (pictured) and associate Vicente Paramio.

An Araoz & Rueda statement said: “The transaction is part of the growth plan of the German multinational to strengthen its international expansion, taking advantage of the knowledge of Euromed of the Spanish market.”

The financial advisers on the transaction were Rothschild, Fidentiis and Ferber & Co.


Araoz & Rueda acts for Dermapharm on €200m Euromed deal

Ben Cook

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram